---
figid: PMC4046703__nihms518689f2
figlink: /pmc/articles/PMC4046703/figure/F2/
number: Figure 2
caption: 'Angiogenesis Inhibitors (VSP Inhibitors) being tested in human cancer trials.
  While these agents are being referred to as VEGF Signaling Pathway (VSP) inhibitors,
  drugs such as sunitinib inhibit many other receptor tyrosine kinases allowing them
  to be approved for the treatment of other cancers while at the same time creating
  the possibility for a wide range of “off-target” toxicities. (Illustration Credit:
  Ben Smith).'
pmcid: PMC4046703
papertitle: Emerging Paradigms in Cardiomyopathies Associated with Cancer Therapies.
reftext: Bonnie Ky, et al. Circ Res. ;113(6):754-764.
pmc_ranked_result_index: '19641'
pathway_score: 0.9706354
filename: nihms518689f2.jpg
figtitle: Angiogenesis Inhibitors (VSP Inhibitors) being tested in human cancer trials
year: ''
organisms: Homo sapiens
ndex: 588bdd5b-dea6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4046703__nihms518689f2.html
  '@type': Dataset
  description: 'Angiogenesis Inhibitors (VSP Inhibitors) being tested in human cancer
    trials. While these agents are being referred to as VEGF Signaling Pathway (VSP)
    inhibitors, drugs such as sunitinib inhibit many other receptor tyrosine kinases
    allowing them to be approved for the treatment of other cancers while at the same
    time creating the possibility for a wide range of “off-target” toxicities. (Illustration
    Credit: Ben Smith).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EPAS1
  - KDR
  - HIF1A
  - FLT1
  - VEGFB
  - FLT4
  - PDGFD
  - ARNTL
  - VEGFA
  - TRRAP
  - ARNT
  - PDGFC
  - KIT
  - PDGFB
  - PGF
  - ARNT2
  - VEGFC
  - PDGFRB
  - HIF3A
  - VEGFD
  - PDGFA
  - PDGFRA
  - Vandetanib
  - Cediranib
  - Brivanib
  - Pazopanib
  - Cabozantinib
  - Regorafenib
  - Prostaglandin
  - Cancer
genes:
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: VEGFR2
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VEGFR1
  symbol: VEGFR1
  source: hgnc_alias_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGFR3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Trap)
  symbol: TR-AP
  source: hgnc_alias_symbol
  hgnc_symbol: TRRAP
  entrez: '8295'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: C-Kit
  symbol: C-Kit
  source: hgnc_alias_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
chemicals:
- word: Vandetanib
  source: MESH
  identifier: C452423
- word: Cediranib
  source: MESH
  identifier: C500926
- word: Brivanib
  source: MESH
  identifier: C509922
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: Cabozantinib
  source: MESH
  identifier: C558660
- word: Regorafenib
  source: MESH
  identifier: C559147
- word: Prostaglandin
  source: MESH
  identifier: D011453
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
